Mediclinic surges as Remgro proposes healthier offer
Remgro and consortium partner MSC have increased their offer to 504p per share for SA’s most valuable hospital group
It was fourth time lucky for Remgro, which has gained support from Mediclinic for its new, higher offer to buy out the private hospital operator after being rejected three times.
Mediclinic shares logged their best gain since mid-October on Thursday after the group said it was willing to consider an improved proposal from a consortium including big shareholder Remgro that values it at £3.7bn (R74bn)...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.